Location History:
- Palo Alto, CA (US) (1982)
- Menlo Park, CA (US) (1986 - 2001)
Company Filing History:
7 out of 7 
5 out of 5 
1 out of 4,455 
Years Active: 1982-2001
Title: The Innovator Jack S. Remington: A Study of His Contributions to Medical Science
Introduction
Jack S. Remington, a prominent inventor based in Menlo Park, California, stands as a significant figure in the field of medical research. With a total of 16 patents to his name, his work primarily centers around the detection and diagnosis of toxoplasmosis, a disease caused by the parasite Toxoplasma gondii. His innovative approaches have contributed to advancements in the medical field, particularly in understanding and diagnosing this infectious disease.
Latest Patents
Remington’s latest patents showcase his ingenuity and dedication. One notable invention is a method of using the P35 antigen of Toxoplasma gondii to distinguish between acute and chronic toxoplasmosis. This invention revolves around the use of combinations or mixtures of antigens that detect specific IgM and IgG antibodies, aiding in the diagnosis of the disease. Additionally, his research includes methods involving these antigens, antibodies raised against them, and kits or vaccines that incorporate these antigens.
Another significant patent involves the Toxoplasma gondii P28 polypeptides, where Remington successfully isolated and characterized the genetic material encoding the P28 peptide. This breakthrough allows for the production of these peptides, which can be utilized in diagnosing or immunizing against the disease, or utilized directly in hybridization assays.
Career Highlights
Throughout his career, Jack S. Remington has collaborated with esteemed institutions, including the Palo Alto Medical Foundation and the Research Institute of Palo Alto Medical Foundation. His work in these organizations has propelled advancements in medical diagnostics and treatment methodologies, demonstrating his commitment to improving healthcare outcomes.
Collaborations
Remington has had the opportunity to work alongside distinguished colleagues, including Fausto G. Araujo and Jeffrey B. Prince. These collaborations have not only enriched his research endeavors but have also fostered a spirit of innovation within the medical research community. Together, they have contributed significantly to the understanding of toxoplasmosis and its implications on human health.
Conclusion
Jack S. Remington's contributions to the field of medical research are commendable, with his innovative patents addressing crucial issues in the diagnosis and understanding of toxoplasmosis. His ongoing work continues to inspire future innovations, reflecting the importance of collaboration and dedication in advancing medical science. With a robust portfolio of patents, Remington remains a pivotal figure in enhancing healthcare through innovation.